Recent achievements in the synthesis of lipids and pharmaceuticals labeled
with tritium are considered. For introduction of the label into unsaturated
compounds, liquid-phase methods were shown to be advantageous over gas-pha
se ones. Thus, tritiation or selective tritiation of compounds with multipl
e bonds may result in preparations with a specific radioactivity of 1-2 PBq
/mol per one reduced bond, whereas isotope exchange with tritium gas may on
ly provide preparations with a specific radioactivity of approximately 0.1
PBq/mol. Solid phase methods of labeling at temperatures above 100 degrees
C are the best for saturated compounds, Isotope exchange with tritium water
or chemical methods (when a high molar radioactivity of up to several PBq/
mol is necessary) may be used in the case of compounds unstable when treate
d with gaseous tritium.